中华医学遗传学杂志
中華醫學遺傳學雜誌
중화의학유전학잡지
CHINESE JOURNAL OF MEDICAL GENETICS
2015年
3期
370-374
,共5页
杨鑫%符芳%李茹%张永玲%万均辉%杨昕%韩瑾%潘敏%甄理
楊鑫%符芳%李茹%張永玲%萬均輝%楊昕%韓瑾%潘敏%甄理
양흠%부방%리여%장영령%만균휘%양흔%한근%반민%견리
颈项透明层增厚%染色体微阵列分析%微缺失%微重复
頸項透明層增厚%染色體微陣列分析%微缺失%微重複
경항투명층증후%염색체미진렬분석%미결실%미중복
Increased nuchal translucency%Chromosomal microarray analysis%Microdeletion%Microduplication
目的 应用染色体微阵列分析技术(chromosomal microarray analysis,CMA)在全基因组水平分析颈项透明层(nuchal translucency,NT)增厚胎儿的遗传学病因.方法 选取78位孕妇早孕期(11+0~13+6孕周)NT厚度≥3.0mm且标准G显带染色体核型分析正常的胎儿样本,首先提取基因组DNA,严格按照美国Affymetrix CytoScanTM HD芯片的标准操作流程进行CMA检测,并应用CHAS软件和相关生物信息学数据库对结果进行分析.CMA检测所得拷贝数变异(copy number variations,CNVs)结果进一步行实时荧光定量PCR验证.结果 CMA在6例胎儿中检出致病性CNVs(7.69%),所检出致病性CNVs片段大小范围为0.41~15.87Mb,其中包含3种已知的微缺失/微重复综合征,分别为:Wolf-Hirschhom综合征、22q11微缺失综合征和ATR-16综合征.中孕期超声结构异常胎儿病例组和无结构异常胎儿病例组致病性CNVs的检出率分别为18.18%(2/11)和5.97%(4/67)(P=0.198,Fisher's检验);致病性CNVs胎儿病例组与非致病性CNVs胎儿病例组NT值的平均数分别是4.48mm和4.22 mm (P=0.735,Mann-Whitney检验).结论 在NT增厚胎儿中,染色体微阵列分析能检测传统核型分析无法识别的染色体微缺失/微重复,对临床产前诊断及遗传咨询具有重要价值,可将疾病诊断率额外提高7.69%.
目的 應用染色體微陣列分析技術(chromosomal microarray analysis,CMA)在全基因組水平分析頸項透明層(nuchal translucency,NT)增厚胎兒的遺傳學病因.方法 選取78位孕婦早孕期(11+0~13+6孕週)NT厚度≥3.0mm且標準G顯帶染色體覈型分析正常的胎兒樣本,首先提取基因組DNA,嚴格按照美國Affymetrix CytoScanTM HD芯片的標準操作流程進行CMA檢測,併應用CHAS軟件和相關生物信息學數據庫對結果進行分析.CMA檢測所得拷貝數變異(copy number variations,CNVs)結果進一步行實時熒光定量PCR驗證.結果 CMA在6例胎兒中檢齣緻病性CNVs(7.69%),所檢齣緻病性CNVs片段大小範圍為0.41~15.87Mb,其中包含3種已知的微缺失/微重複綜閤徵,分彆為:Wolf-Hirschhom綜閤徵、22q11微缺失綜閤徵和ATR-16綜閤徵.中孕期超聲結構異常胎兒病例組和無結構異常胎兒病例組緻病性CNVs的檢齣率分彆為18.18%(2/11)和5.97%(4/67)(P=0.198,Fisher's檢驗);緻病性CNVs胎兒病例組與非緻病性CNVs胎兒病例組NT值的平均數分彆是4.48mm和4.22 mm (P=0.735,Mann-Whitney檢驗).結論 在NT增厚胎兒中,染色體微陣列分析能檢測傳統覈型分析無法識彆的染色體微缺失/微重複,對臨床產前診斷及遺傳咨詢具有重要價值,可將疾病診斷率額外提高7.69%.
목적 응용염색체미진렬분석기술(chromosomal microarray analysis,CMA)재전기인조수평분석경항투명층(nuchal translucency,NT)증후태인적유전학병인.방법 선취78위잉부조잉기(11+0~13+6잉주)NT후도≥3.0mm차표준G현대염색체핵형분석정상적태인양본,수선제취기인조DNA,엄격안조미국Affymetrix CytoScanTM HD심편적표준조작류정진행CMA검측,병응용CHAS연건화상관생물신식학수거고대결과진행분석.CMA검측소득고패수변이(copy number variations,CNVs)결과진일보행실시형광정량PCR험증.결과 CMA재6례태인중검출치병성CNVs(7.69%),소검출치병성CNVs편단대소범위위0.41~15.87Mb,기중포함3충이지적미결실/미중복종합정,분별위:Wolf-Hirschhom종합정、22q11미결실종합정화ATR-16종합정.중잉기초성결구이상태인병례조화무결구이상태인병례조치병성CNVs적검출솔분별위18.18%(2/11)화5.97%(4/67)(P=0.198,Fisher's검험);치병성CNVs태인병례조여비치병성CNVs태인병례조NT치적평균수분별시4.48mm화4.22 mm (P=0.735,Mann-Whitney검험).결론 재NT증후태인중,염색체미진렬분석능검측전통핵형분석무법식별적염색체미결실/미중복,대림상산전진단급유전자순구유중요개치,가장질병진단솔액외제고7.69%.
Objective To explore the genetic etiology for fetuses with increased nuchal translucency (NT) but a normal karyotype at whole genome level by chromosome microarray analysis (CMA).Methods Seventy-eight fetuses with increased NT(≥ 3.0 mm) but a normal karyotype were collected between 11+0 and 13+6 gestational weeks.Genomic DNA was extracted,and microarray testing was performed using Affymetrix CytoScanTM HD arrays.The data was analyzed by CHAS software.All detected copy number variations (CNVs) were confirmed with real-time quantitative polymerase chain reaction.Results The CMA assay has detected pathogenic CNVs in 6 fetuses (7.69%),which have ranged from 0.41 Mb to 15.87 Mb.Well-known microdeletion or microduplication syndromes including Wolf-Hirschhorn syndrome,22q11 microdeletion syndrome and ATR-16 syndrome were identified in three cases.The detection rates in fetuses with or without structural abnormalities were 18.18% and 5.97%,respectively (P=0.198 with Fisher's Exact Test).The average NT in fetuses with pathogenic CNVs and non-pathogenic CNVs has measured 4.48 mm and 4.22 mm (P=0.735 by Mann-Whitney Test).Conclusion For fetuses with increased NT,CMA can identify chromosomal microdeletion/microduplication unrecognizable by conventional karyotyping analysis.It may therefore play an important role in prenatal diagnosis and genetic counseling by improving the diagnostic rate.